IRINOTECAN

Course overview

IRINOTECAN IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF A VARIETY OF SOLID TUMORS. IT IS IN THE DNA TOPOISOMERASE I INHIBITOR CLASS OF DRUGS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR IRINOTECAN AS A VALUABLE AGENT IN TREATING SOLID TUMORS SUCH AS COLORECTAL, PANCREATIC, OVARIAN, AND LUNG CANCERS. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE HEALTHCARE TEAM IN THE CARE OF PATIENTS WHO RECEIVE TREATMENT WITH THIS MEDICATION.